Docking & Screening Comparison
DiffDock vs GNINA vs AutoDock Vina: Molecular Docking Compared (2026)
Last updated: 2026-04-16
Molecular docking is the workhorse of structure-based drug discovery. AutoDock Vina has been the default open-source tool for over a decade. GNINA augmented Vina with CNN-based scoring. DiffDock took a completely different approach — treating docking as a generative problem using diffusion models. Each has distinct strengths depending on your use case.
DiffDock / DiffDock-L
MIT CSAIL (Corso et al.)
GNINA
Koes Lab (University of Pittsburgh)
AutoDock Vina
The Scripps Research Institute
Head-to-Head
Structured comparison across key dimensions.
| Dimension | DiffDock / DiffDock-L | GNINA | AutoDock Vina |
|---|---|---|---|
| Approach | Diffusion-based generative model | Vina sampling + CNN re-scoring | Classical empirical scoring + Monte Carlo optimization |
| Binding site required? | No — blind docking native | Yes — must define a box | Yes — must define a box |
| GPU required? | Yes (practical requirement) | Yes (for CNN scoring) | No (CPU-only) |
| Throughput | Low-medium (~100s of compounds/day) | Medium (~1,000s of compounds/day) | High (~10,000s of compounds/day; Uni-Dock: millions) |
| Pose accuracy | 43% top-1 success (DiffDock-L, RMSD <2A) | 85% success rate on kinases | Good for known sites; degrades on flexible targets |
| Scoring | Confidence score (not binding energy) | CNN affinity score + Vina score | Empirical binding energy estimate (kcal/mol) |
| License | MIT | Open source | Apache 2.0 |
| On Platform | Yes (DiffDock-L) | Yes | Partial (via DiffDock-L pipeline) |
| Key limitation | Underperforms physics-based on cross-docking; no binding free energies | Training set bias on novel scaffold classes | Rigid receptor; scoring accuracy limited on flexible targets |
When to Use Each
DiffDock / DiffDock-L
You don't know the binding site (blind docking). You want diverse generative pose hypotheses. You're screening a focused library (<1,000 compounds) and need creative pose generation.
GNINA
You have a known binding site and want better enrichment than Vina. You have GPU access. You're running medium-scale virtual screening where pose accuracy matters more than raw speed.
AutoDock Vina
You need maximum throughput for large libraries. You have a well-defined binding pocket. You want the most widely validated, lowest-risk option for a first-pass screen.
Practitioner Verdict
Use Vina for large-scale virtual screening where you need speed and a well-defined binding site. Use GNINA when you need better enrichment (fewer false positives) and have GPU access. Use DiffDock when you don't know the binding site (blind docking) or want to generate diverse pose hypotheses. For the highest confidence, run two methods and look for consensus.
Stay updated on these tools
Weekly briefing on AI tool releases, benchmarks, and what works in drug discovery.